Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
11.78
+0.15 (1.29%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Design Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
54
Market Cap
735.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDSGN News
- 24 days ago - Design Therapeutics initiates patient dosing in DT-818 trial - TheFly
- 25 days ago - Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1 - GlobeNewsWire
- 7 weeks ago - Design Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Design Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Design Therapeutics Transcript: Status update - Transcripts
- 2 months ago - Design Therapeutics Press release: Status update - Filings
- 2 months ago - Design Therapeutics Slides: Status update - Filings